Literature DB >> 25179793

Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis.

Layal Chaker1, Christine Baumgartner, M Arfan Ikram, Abbas Dehghan, Marco Medici, W Edward Visser, Albert Hofman, Nicolas Rodondi, Robin P Peeters, Oscar H Franco.   

Abstract

Subclinical thyroid dysfunction has been associated with coronary heart disease, but the risk of stroke is unclear. Our aim is to combine the evidence on the association between subclinical thyroid dysfunction and the risk of stroke in prospective cohort studies. We searched Medline (OvidSP), Embase, Web-of-Science, Pubmed Publisher, Cochrane and Google Scholar from inception to November 2013 using a cohort filter, but without language restriction or other limitations. Reference lists of articles were searched. Two independent reviewers screened articles according to pre-specified criteria and selected prospective cohort studies with baseline thyroid function measurements and assessment of stroke outcomes. Data were derived using a standardized data extraction form. Quality was assessed according to previously defined quality indicators by two independent reviewers. We pooled the outcomes using a random-effects model. Of 2,274 articles screened, six cohort studies, including 11,309 participants with 665 stroke events, met the criteria. Four of six studies provided information on subclinical hyperthyroidism including a total of 6,029 participants and five on subclinical hypothyroidism (n = 10,118). The pooled hazard ratio (HR) was 1.08 (95 % CI 0.87-1.34) for subclinical hypothyroidism (I (2) of 0 %) and 1.17 (95 % CI 0.54-2.56) for subclinical hyperthyroidism (I (2) of 67 %) compared to euthyroidism. Subgroup analyses yielded similar results. Our systematic review provides no evidence supporting an increased risk for stroke associated with subclinical thyroid dysfunction. However, the available literature is insufficient and larger datasets are needed to perform extended analyses. Also, there were insufficient events to exclude clinically significant risk from subclinical hyperthyroidism, and more data are required for subgroup analyses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25179793     DOI: 10.1007/s10654-014-9946-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  45 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Cardiovascular events in thyroid disease: a population based, prospective study.

Authors:  M Schultz; C Kistorp; I Raymond; J Dimsits; C Tuxen; P Hildebrandt; J Faber
Journal:  Horm Metab Res       Date:  2011-08-05       Impact factor: 2.936

5.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.

Authors:  J V Parle; P Maisonneuve; M C Sheppard; P Boyle; J A Franklyn
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

6.  Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants.

Authors:  C Pirich; M Müllner; H Sinzinger
Journal:  J Clin Epidemiol       Date:  2000-06       Impact factor: 6.437

7.  The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey.

Authors:  F Aghini-Lombardi; L Antonangeli; E Martino; P Vitti; D Maccherini; F Leoli; T Rago; L Grasso; R Valeriano; A Balestrieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

8.  Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.

Authors:  Nicolas Ochs; Reto Auer; Douglas C Bauer; David Nanchen; Jacobijn Gussekloo; Jacques Cornuz; Nicolas Rodondi
Journal:  Ann Intern Med       Date:  2008-05-19       Impact factor: 25.391

9.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.

Authors:  F Monzani; N Caraccio; M Kozàkowà; A Dardano; F Vittone; A Virdis; S Taddei; C Palombo; E Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

10.  Subclinical hypothyroidism and risk for incident ischemic stroke among postmenopausal women.

Authors:  Ayush Giri; Todd L Edwards; Vicky A LeGrys; Carol E Lorenz; Michele Jonsson Funk; Robin Schectman; Gerardo Heiss; Jennifer G Robinson; Katherine E Hartmann
Journal:  Thyroid       Date:  2014-06-16       Impact factor: 6.568

View more
  13 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

Review 2.  Pulmonary hypertension in thyroid diseases.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Francesco Tunzi; Gabriella Ricci; Santa Carbonara; Fiorella Devito; Annapaola Zito; Anna Ciampolillo; Marco Matteo Ciccone
Journal:  Endocrine       Date:  2016-03-19       Impact factor: 3.633

3.  Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Seth S Martin; Natalie Daya; Pamela L Lutsey; Kunihiro Matsushita; Anna Fretz; John W McEvoy; Roger S Blumenthal; Josef Coresh; Philip Greenland; Anna Kottgen; Elizabeth Selvin
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

4.  The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II.

Authors:  S A Paul Chubb; Kirsten E Peters; David G Bruce; Wendy A Davis; Timothy M E Davis
Journal:  Acta Diabetol       Date:  2022-09-09       Impact factor: 4.087

5.  Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis.

Authors:  Layal Chaker; Christine Baumgartner; Wendy P J den Elzen; Tinh-Hai Collet; M Arfan Ikram; Manuel R Blum; Abbas Dehghan; Christiane Drechsler; Robert N Luben; Marileen L P Portegies; Giorgio Iervasi; Marco Medici; David J Stott; Robin P Dullaart; Ian Ford; Alexandra Bremner; Anne B Newman; Christoph Wanner; José A Sgarbi; Marcus Dörr; W T Longstreth; Bruce M Psaty; Luigi Ferrucci; Rui M B Maciel; Rudi G Westendorp; J Wouter Jukema; Graziano Ceresini; Misa Imaizumi; Albert Hofman; Stephan J L Bakker; Jayne A Franklyn; Kay-Tee Khaw; Douglas C Bauer; John P Walsh; Salman Razvi; Jacobijn Gussekloo; Henry Völzke; Oscar H Franco; Anne R Cappola; Nicolas Rodondi; Robin P Peeters
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

6.  The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.

Authors:  Bernadette Biondi; Luigi Bartalena; David S Cooper; Laszlo Hegedüs; Peter Laurberg; George J Kahaly
Journal:  Eur Thyroid J       Date:  2015-08-26

Review 7.  Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.

Authors:  Layal Chaker; Christine Baumgartner; Wendy P J den Elzen; M Arfan Ikram; Manuel R Blum; Tinh-Hai Collet; Stephan J L Bakker; Abbas Dehghan; Christiane Drechsler; Robert N Luben; Albert Hofman; Marileen L P Portegies; Marco Medici; Giorgio Iervasi; David J Stott; Ian Ford; Alexandra Bremner; Christoph Wanner; Luigi Ferrucci; Anne B Newman; Robin P Dullaart; José A Sgarbi; Graziano Ceresini; Rui M B Maciel; Rudi G Westendorp; J Wouter Jukema; Misa Imaizumi; Jayne A Franklyn; Douglas C Bauer; John P Walsh; Salman Razvi; Kay-Tee Khaw; Anne R Cappola; Henry Völzke; Oscar H Franco; Jacobijn Gussekloo; Nicolas Rodondi; Robin P Peeters
Journal:  J Clin Endocrinol Metab       Date:  2015-04-09       Impact factor: 5.958

8.  Long-term cardiovascular and cerebrovascular morbidity in Israeli thyroid cancer survivors.

Authors:  Elena Izkhakov; Joseph Meyerovitch; Micha Barchana; Yacov Shacham; Naftali Stern; Lital Keinan-Boker
Journal:  Endocr Connect       Date:  2019-04       Impact factor: 3.335

9.  Hypothyroidism and related diseases: a methodological quality assessment of meta-analysis.

Authors:  Limin Tian; Feifei Shao; Yahong Qin; Qian Guo; Cuixia Gao
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

10.  Treatment of Thyroid Dysfunctions Decreases the Risk of Cerebrovascular Events in Men but Not in Women: Results of the MONICA/KORA Cohort Study.

Authors:  Julia Six-Merker; Christa Meisinger; Carolin Jourdan; Margit Heier; Hans Hauner; Annette Peters; Jakob Linseisen
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.